Proton pump inhibitors — PPIs — are among the most prescribed and most purchased drugs in the United States. Omeprazole (Prilosec), esomeprazole (Nexium), pantoprazole (Protonix), lansoprazole (Prevacid) — they are available over the counter and by prescription, and approximately 15 million Americans take them daily, many for years or decades. They are presented as straightforward stomach acid reducers — safe enough to buy without a prescription, appropriate for long-term daily use, essentially inert beyond their intended effect.
None of that is accurate. PPIs are powerful drugs with systemic effects that extend far beyond the stomach. Long-term use is associated with magnesium deficiency, B12 deficiency, increased fracture risk, kidney disease, dementia, C. difficile infection, small intestinal bacterial overgrowth (SIBO), and pneumonia. And they create a physiological dependency — acid rebound hypersecretion — that makes stopping them genuinely difficult and that traps many people in long-term use that was never intended when they first picked up the box.
WHAT STOMACH ACID ACTUALLY DOES
Stomach acid — hydrochloric acid, with a pH of 1.5 to 3.5 — is not a design flaw or an excess that needs to be suppressed. It is essential for digestion and for protection against pathogens. Stomach acid begins protein digestion by activating the enzyme pepsin. It is required for the absorption of several critical nutrients including B12, iron, calcium, magnesium, and zinc. It sterilizes food before it reaches the small intestine — killing most of the bacteria, parasites, and viruses that would otherwise colonize the gut. And it triggers the cascade of digestive hormone signals that regulate the rest of the digestive process.
When stomach acid is chronically suppressed by PPIs, all of these functions are impaired. This is the mechanism behind most of the long-term PPI risks — they are the predictable downstream consequences of blocking a system that the body depends on.
THE RISKS BURIED IN LONG-TERM USE
Magnesium deficiency: PPIs impair magnesium absorption from the gut. The FDA issued a safety communication about this in 2011, noting that hypomagnesemia can cause muscle spasms, irregular heartbeat, and seizures. Chronic low-level magnesium deficiency from PPI use — the level that does not cause acute symptoms but depletes the body’s magnesium reserve over time — is associated with cardiovascular disease, insulin resistance, depression, migraine, muscle cramping, and sleep disruption. Magnesium levels are rarely monitored in PPI users.
B12 deficiency: Stomach acid is required to cleave B12 from food proteins so it can bind to intrinsic factor for absorption. PPI suppression of acid impairs this initial cleavage step, reducing B12 absorption from food. Long-term PPI users have significantly higher rates of B12 deficiency than non-users. B12 deficiency causes peripheral neuropathy, cognitive decline, depression, and megaloblastic anemia — symptoms that can progress silently over years before becoming clinically apparent.
Bone fracture: The FDA added a fracture warning to PPI labels in 2010. The mechanism involves impaired calcium absorption, potentially leading to reduced bone mineral density with long-term use. Multiple large studies have found increased hip, wrist, and spine fracture risk in long-term PPI users.
Kidney disease: Multiple studies have found associations between PPI use and acute kidney injury, chronic kidney disease, and progression to end-stage renal disease. A 2016 study in JAMA Internal Medicine found that PPI users had a 20-50% higher risk of chronic kidney disease than non-users, with risk increasing with duration of use.
Dementia: A 2016 German study of approximately 74,000 adults found that regular PPI use was associated with a 44% increased risk of dementia. The B12 depletion mechanism is one proposed pathway. This association has not been confirmed in all subsequent studies and causation is not established, but the signal is present in the epidemiological literature.
SIBO and C. difficile: Suppressing stomach acid removes the primary barrier to bacterial colonization of the small intestine and upper GI tract. Small intestinal bacterial overgrowth (SIBO) is significantly more common in PPI users. C. difficile infection risk is also significantly elevated — for the same reason that antibiotic use increases C. diff risk.
REBOUND ACID HYPERSECRETION — WHY STOPPING IS SO HARD
This is the dependency mechanism that traps people in PPI use, and it is almost never disclosed when PPIs are first prescribed or purchased.
When stomach acid is suppressed by PPIs, the body responds by upregulating gastrin — a hormone that signals for more acid production — and by proliferating the acid-secreting parietal cells in the stomach lining. When PPIs are discontinued, this upregulated acid-secretion capacity is suddenly unleashed — producing acid at levels significantly higher than before the PPI was ever started. This rebound acid hypersecretion causes severe heartburn and reflux that is worse than the original symptoms.
Most people interpret this rebound acid surge as proof that they need the PPI — that their acid problem is worse than ever. They restart the PPI. The cycle repeats. Many people who started PPIs for a short-term indication end up on them for years or decades because stopping them causes symptoms that feel medically necessary to treat, when in fact those symptoms are caused by the drug itself.
Discontinuing PPIs requires a gradual taper — reducing dose slowly over weeks to months — to allow the upregulated acid-secretion system to normalize. This is not how PPIs are typically managed by prescribers or described on OTC packaging.
WHAT ACTUALLY CAUSES ACID REFLUX
The dominant medical narrative frames acid reflux as too much stomach acid. For the majority of acid reflux sufferers, this is wrong. The actual mechanism in most GERD is lower esophageal sphincter (LES) dysfunction — the valve between the esophagus and stomach that is supposed to prevent acid from moving upward is not closing properly. The amount of acid is often normal; the problem is where it goes. In many cases, low stomach acid is actually a contributing factor — inadequate acid impairs proper digestion and the pressure dynamics that keep the LES closed.
Factors that impair LES function: excess weight, hiatal hernia, overeating, eating immediately before lying down, alcohol, caffeine, chocolate, high-fat meals, smoking, and certain medications. Addressing these upstream causes resolves reflux for many people without acid suppression.
SUPPORTING YOUR BODY
For those tapering PPIs: Work with a physician on a gradual taper schedule. During the taper, H2 blockers (famotidine/Pepcid) can bridge the rebound period — they work differently from PPIs and do not cause the same rebound hypersecretion. Expect some rebound symptoms regardless and understand they are withdrawal, not relapse.
Deglycyrrhizinated licorice (DGL): Chewed DGL tablets before meals coat and soothe the mucosa, reducing irritation without suppressing acid. Significant clinical evidence for esophageal and gastric protection.
Marshmallow root: Cold infusion of marshmallow root is one of the most effective demulcent preparations for coating and soothing the GI tract from esophagus to colon. Particularly effective when prepared as a cold infusion — boiling degrades the mucilaginous compounds. See the Herbal Remedies section for preparation details.
Slippery elm bark: Another demulcent with long traditional use for esophageal and stomach irritation. Can be made as a thin porridge or taken as powder mixed with water.
Addressing root causes: Elevating the head of the bed 6-8 inches, not eating within 3 hours of lying down, smaller meals, identifying and removing dietary triggers, weight management — these address the actual mechanism and produce lasting resolution rather than indefinite suppression.
Mineral repletion for long-term PPI users: Magnesium glycinate (well-absorbed), sublingual B12, calcium from food sources, zinc. Monitoring blood levels annually if long-term PPI use has been the history.
Cross-reference: Know Your Medication — Antibiotics | Know Your Body | Herbal Remedies | Flora Archive | Root Cellar
FROM THE WASTELAND
Leaf Juice — Wasteland Survival Series, Book 1
Marshmallow root cold infusion, DGL preparations, slippery elm bark, and the gut lining repair herbs in this post have full preparation protocols in Leaf Juice.
Paperback | Kindle